Thioureidobutyronitrile: Interim Phase I data

Interim data from 1 patient with stage IV thymoma in his eleventh month of treatment in an open-label, dose-escalation,

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE